Idogen works in a close scientific collaboration with a very prominent research group to develop Idogen’s treatment method for an additional indication, rheumatoid arthritis.
Professor Richard Williams at the Kennedy institute, Oxfords universitet.
Professor Williams’ research group develop new therapeutic strategies for the treatment of rheumatoid arthritis. His previous work has contributed to a successful development of the TNF-alfa-inhibitors, a major advance in the treatment of rheumatoid arthritis, Crohn’s disease, psoriasis and other inflammatory diseases. Idogen and professor William’s research group cooperate in the preclinical development to customize our unique treatment method for rheumatoid arthritis.